These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 33168055)

  • 1. Modern treatment outcomes for early T-stage oropharyngeal cancer treated with intensity-modulated radiation therapy at a tertiary care institution.
    Di Gravio EJ; Lang P; Kim HAJ; Chinnery T; Mundi N; MacNeil SD; Mendez A; Yoo J; Fung K; Mymryk JS; Barrett JW; Read N; Venkatesan V; Kuruvilla S; Mendez LC; Winquist E; Mitchell S; Mattonen SA; Nichols AC; Palma DA
    Radiat Oncol; 2020 Nov; 15(1):261. PubMed ID: 33168055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in Functional and Survival Outcomes Between Patients Receiving Primary Surgery vs Chemoradiation Therapy for Treatment of T1-T2 Oropharyngeal Squamous Cell Carcinoma.
    Amin DR; Philips R; Bertoni DG; Mastrolonardo EV; Campbell DJ; Agarwal AM; Tekumalla S; Urdang ZD; Luginbuhl AJ; Cognetti DM; Curry JM
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):980-986. PubMed ID: 37422846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of Survival After Transoral Robotic Surgery vs Nonrobotic Surgery in Patients With Early-Stage Oropharyngeal Squamous Cell Carcinoma.
    Nguyen AT; Luu M; Mallen-St Clair J; Mita AC; Scher KS; Lu DJ; Shiao SL; Ho AS; Zumsteg ZS
    JAMA Oncol; 2020 Oct; 6(10):1555-1562. PubMed ID: 32816023
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of outcomes using intensity-modulated radiation therapy and 3-dimensional conformal radiation therapy in treatment of oropharyngeal cancer.
    Lohia S; Rajapurkar M; Nguyen SA; Sharma AK; Gillespie MB; Day TA
    JAMA Otolaryngol Head Neck Surg; 2014 Apr; 140(4):331-7. PubMed ID: 24557509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative cost analysis between definitive radiotherapy and transoral surgery for oropharyngeal squamous cell carcinoma: A SEER-Medicare analysis.
    Sher DJ; Yan J; Day AT; Khan S; Zhu H
    Oral Oncol; 2021 Jan; 112():105029. PubMed ID: 33142225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of margins and survival between transoral robotic surgery (TORS) and non-robotic endoscopic surgery for oropharyngeal cancer.
    Groysman M; Gleadhill C; Baker A; Wang SJ; Bearelly S
    Am J Otolaryngol; 2023; 44(6):103982. PubMed ID: 37531886
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upfront transoral robotic surgery (TORS)
    Zorzi SF; Agostini G; Chu F; Tagliabue M; Pietrobon G; Corrao G; Volpe S; Marvaso G; Colombo F; Cossu Rocca M; Gandini S; Gaeta A; Ruju F; Alterio D; Ansarin M
    Acta Otorhinolaryngol Ital; 2022 Aug; 42(4):334-347. PubMed ID: 35938555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment.
    Cramer JD; Ferris RL; Kim S; Duvvuri U
    Oral Oncol; 2018 Dec; 87():170-176. PubMed ID: 30527235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ Locally Advanced Oropharynx Cancer: An ECOG-ACRIN Cancer Research Group Trial (E3311).
    Ferris RL; Flamand Y; Weinstein GS; Li S; Quon H; Mehra R; Garcia JJ; Chung CH; Gillison ML; Duvvuri U; O'Malley BW; Ozer E; Thomas GR; Koch WM; Gross ND; Bell RB; Saba NF; Lango M; Méndez E; Burtness B
    J Clin Oncol; 2022 Jan; 40(2):138-149. PubMed ID: 34699271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multi-institution pooled analysis of gastrostomy tube dependence in patients with oropharyngeal cancer treated with definitive intensity-modulated radiotherapy.
    Setton J; Lee NY; Riaz N; Huang SH; Waldron J; O'Sullivan B; Zhang Z; Shi W; Rosenthal DI; Hutcheson KA; Garden AS
    Cancer; 2015 Jan; 121(2):294-301. PubMed ID: 25286832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in surgically resectable oropharynx cancer treated with transoral robotic surgery versus definitive chemoradiation.
    Dhanireddy B; Burnett NP; Sanampudi S; Wooten CE; Slezak J; Shelton B; Shelton L; Shearer A; Arnold S; Kudrimoti M; Gal TJ
    Am J Otolaryngol; 2019; 40(5):673-677. PubMed ID: 31201038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
    Smith RV; Schiff BA; Garg M; Haigentz M
    Laryngoscope; 2015 Nov; 125 Suppl 10():S1-S15. PubMed ID: 26436491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Outcomes and Patterns of Disease Recurrence After Intensity Modulated Proton Therapy for Oropharyngeal Squamous Carcinoma.
    Gunn GB; Blanchard P; Garden AS; Zhu XR; Fuller CD; Mohamed AS; Morrison WH; Phan J; Beadle BM; Skinner HD; Sturgis EM; Kies MS; Hutcheson KA; Rosenthal DI; Mohan R; Gillin MT; Frank SJ
    Int J Radiat Oncol Biol Phys; 2016 May; 95(1):360-367. PubMed ID: 27084653
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial.
    Nichols AC; Theurer J; Prisman E; Read N; Berthelet E; Tran E; Fung K; de Almeida JR; Bayley A; Goldstein DP; Hier M; Sultanem K; Richardson K; Mlynarek A; Krishnan S; Le H; Yoo J; MacNeil SD; Winquist E; Hammond JA; Venkatesan V; Kuruvilla S; Warner A; Mitchell S; Chen J; Corsten M; Johnson-Obaseki S; Eapen L; Odell M; Parker C; Wehrli B; Kwan K; Palma DA
    Lancet Oncol; 2019 Oct; 20(10):1349-1359. PubMed ID: 31416685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of cervical node positivity, regional failure rates, and fistula rates for HPV+ oropharyngeal squamous cell carcinoma treated with transoral robotic surgery (TORS).
    Cannon RB; Houlton JJ; Patel S; Raju S; Noble A; Futran ND; Parvathaneni U; Méndez E
    Oral Oncol; 2018 Nov; 86():296-300. PubMed ID: 30409315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of up-front transoral robotic surgery in tailoring adjuvant therapy.
    Gildener-Leapman N; Kim J; Abberbock S; Choby GW; Mandal R; Duvvuri U; Ferris RL; Kim S
    Head Neck; 2016 Aug; 38(8):1201-7. PubMed ID: 27225507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary transoral robotic surgery with concurrent neck dissection for early stage oropharyngeal squamous cell carcinoma implemented at a Danish head and neck cancer center: a phase II trial on feasibility and tumour margin status.
    Rubek N; Channir HI; Charabi BW; Lajer CB; Kiss K; Nielsen HU; Bentzen J; Friborg J; von Buchwald C
    Eur Arch Otorhinolaryngol; 2017 May; 274(5):2229-2237. PubMed ID: 28050651
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary transoral robotic surgery +/- adjuvant therapy for oropharyngeal squamous cell carcinoma-A large observational single-centre series from the United Kingdom.
    O'Hara J; Warner L; Fox H; Hamilton D; Meikle D; Counter P; Robson A; Goranova R; Iqbal S; Kelly C; Robinson M; Paleri V
    Clin Otolaryngol; 2021 Sep; 46(5):1005-1012. PubMed ID: 33754476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ACR Appropriateness Criteria(®) Locoregional therapy for resectable oropharyngeal squamous cell carcinomas.
    Beitler JJ; Quon H; Jones CU; Salama JK; Busse PM; Cooper JS; Koyfman SA; Ridge JA; Saba NF; Siddiqui F; Smith RV; Worden F; Yao M; Yom SS;
    Head Neck; 2016 Sep; 38(9):1299-309. PubMed ID: 27330003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncological outcome following initiation of treatment for stage III and IV HPV negative oropharyngeal cancers with transoral robotic surgery (TORS).
    Dabas S; Gupta K; Sharma AK; Shukla H; Ranjan R; Sharma DK
    Eur J Surg Oncol; 2019 Nov; 45(11):2137-2142. PubMed ID: 31239156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.